TherapeuticsMD ( NASDAQ:TXMD ) Third Quarter 2024 Results Key Financial Results Net loss: US$567.0k (loss narrowed by... BOCA RATON, Fla., November 12, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD ...
BOCA RATON, Fla., November 12, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback